Skip to content
The Kids Research Institute Australia logo
Donate

No results yet

Search

Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity

Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity In response to repeated lung infection

The AREST CF experience in biobanking — More than just tissues, tubes and time

The AREST CF experience in biobanking — More than just tissues, tubes and time Abstract Research to further improve outcomes for people with CF is

CrossTalk opposing view: mucosal acidification does not drive early progressive lung disease in cystic fibrosis

CrossTalk opposing view: mucosal acidification does not drive early progressive lung disease in cystic fibrosis CrossTalk opposing view: mucosal

Working with the community

Community involvement plays an integral role in guiding our research - find out how.

START Phage WA

START Phage WA was formed to pave the way towards treating AMR infections with phage therapy in Western Australia.

Effect of Posture on Lung Ventilation distribution and Associations with Structure in Children with Cystic Fibrosis

Effect of Posture on Lung Ventilation distribution and Associations with Structure in Children with Cystic Fibrosis Effect of Posture on Lung

Alpha-1 Antitrypsin Mitigates the Inhibition of Airway Epithelial Cell Repair by Neutrophil Elastase

Alpha-1 Antitrypsin Mitigates the Inhibition of Airway Epithelial Cell Repair by Neutrophil Elastase Abstract Neutrophil elastase (NE) activity is

Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis

Interleukin-1 is associated with inflammation and structural lung disease in young children with cystic fibrosis Early diagnosis and treatment in

Research

Prophylactic use of sublingual allergen immunotherapy in high-risk children: A pilot study

These findings suggest that this modified version of SLIT should be considered for retesting of mucosal-based immunotherapy for atopic asthma prevention.